Scolaris Content Display Scolaris Content Display

Cochrane Database of Systematic Reviews

Sequencing of anthracyclines and taxanes in neoadjuvant and adjuvant therapy for early breast cancer

This is not the most recent version

view the current version 18 February 2019

Information

DOI:
https://doi.org/10.1002/14651858.CD012873Copy DOI
Database:
  1. Cochrane Database of Systematic Reviews
Version published:
  1. 21 November 2017see what's new
Type:
  1. Intervention
Stage:
  1. Protocol
Cochrane Editorial Group:

  1. Cochrane Breast Cancer Group

Copyright:
  1. Copyright © 2017 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

Article metrics

Altmetric:

Cited by:

Cited 0 times via Crossref Cited-by Linking

Collapse

Authors

  • Milita Zaheed

    Correspondence to: Medical Oncology Department, Concord Repatriation General Hospital, Concord, Australia

    [email protected]

  • Nicholas Wilcken

    Medical Oncology, Crown Princess Mary Cancer Centre, Westmead, Australia

    Sydney Medical School, The University of Sydney, Sydney, Australia

  • Melina L Willson

    Systematic Reviews and Health Technology Assessments, NHMRC Clinical Trials Centre, The University of Sydney, Sydney, Australia

  • Dianne L O'Connell

    Cancer Research Division, Cancer Council NSW, Sydney, Australia

  • Annabel Goodwin

    Medical Oncology Department, Concord Repatriation General Hospital, Concord, Australia

    Concord Clinical School, The University of Sydney, Concord Repatriation General Hospital, Concord, Australia

    Cancer Genetics Department, Sydney Local Health District and South Western Sydney Local Health District, Sydney, Australia

Contributions of authors

  1. Drafting the protocol: MZ and AG

  2. Study selection: MZ and AG

  3. Extracting data from studies: MZ and MW

  4. Entering data into RevMan: MZ

  5. Carrying out the analysis: MZ, MW and DO'C

  6. Interpreting the analysis: MZ, AG, MW, NW and DO'C

  7. Drafting the final review: MZ, AG, MW, NW and DO'C

  8. Disagreement resolution: AG, NW, MW, DO'C

  9. Updating the review: MZ

Sources of support

Internal sources

  • None, Other.

External sources

  • None, Other.

Declarations of interest

MZ: none known
MLW: none known
NW: none known
DO'C: none known
AG: none known

Acknowledgements

We would like to acknowledge the help received from Slavica Berber, Information Specialist at the Cochrane Breast Cancer Group, for developing the search strategies.

Version history

Published

Title

Stage

Authors

Version

2019 Feb 18

Sequencing of anthracyclines and taxanes in neoadjuvant and adjuvant therapy for early breast cancer

Review

Milita Zaheed, Nicholas Wilcken, Melina L Willson, Dianne L O'Connell, Annabel Goodwin

https://doi.org/10.1002/14651858.CD012873.pub2

2017 Nov 21

Sequencing of anthracyclines and taxanes in neoadjuvant and adjuvant therapy for early breast cancer

Protocol

Milita Zaheed, Nicholas Wilcken, Melina L Willson, Dianne L O'Connell, Annabel Goodwin

https://doi.org/10.1002/14651858.CD012873

Keywords

MeSH

Medical Subject Headings (MeSH) Keywords

Medical Subject Headings Check Words

Female; Humans;

PICOs

Population
Intervention
Comparison
Outcome

The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome.

See more on using PICO in the Cochrane Handbook.